CCN2 and familial pancreatic carcinoma: The results showed that GPRC5A positively regulated YAP1, CYR61, cyclin D1, c-Myc and CTGF expression at the transcriptional level, as evidenced by overexpression and knockdown of GPRC5A in pancreatic cancer cells (Fig. 5H, L).